Skip to main content

Baird Capital leads Atlanta cancer treatment analytics startup's $28M funding round

An Atlanta-based data-driven utilization management company with a focus on oncology has raised $28 million in a Series C round led by Baird Capital.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.